Eagle: ‘No Room, No Reason’ For A Generics Business, As Vasopressin Pulled
US-Based Firm Will Not Rule Out Returning To Market – ‘If Things Change’
Executive Summary
In something of a surprise, Eagle Pharmaceuticals has announced its exit from the generic vasopressin market – one year after a hard-fought and hard-won launch.